CD14+CD16+ monocytes in coronary artery disease and their relationship to serum TNF-alpha levels
- PMID: 15269840
- DOI: 10.1160/TH04-02-0095
CD14+CD16+ monocytes in coronary artery disease and their relationship to serum TNF-alpha levels
Abstract
Monocytes play a central role in the inflammatory disease atherosclerosis. CD14+CD16+ monocytes are considered proinflammatory monocytes, as they have an increased capacity to produce proinflammatory cytokines, such as TNF-alpha, and are elevated in various inflammatory diseases. We hypothesized that patients with coronary artery disease (CAD) have increased levels of CD14+CD16+ monocytes, and that CD14+CD16+ monocytes are associated with inflammation markers. We investigated CD14+CD16+ monocytes in 247 patients with CAD and 61 control subjects using flow cytometry. In addition serum concentrations of TNF-alpha, IL-6, and Hs-CRP were assessed. Patients with CAD had higher levels of CD14+CD16+ monocytes than controls (13.6% versus 11.4%; p<0.001). Logistic regression analysis including quartiles of CD14+CD16+ monocytes showed that CD14+CD16+ monocytes were associated with prevalence of CAD (OR 4.9, 95% CI 2.5-19.1, for subjects in the fourth quartile in comparison to subjects in the first quartile). The association between CD14+CD16+ monocytes and CAD remained independently significant after adjustment for most potential confounders (OR 5.0, 95% CI 1.2-20.0). Serum concentrations of TNF-alpha were elevated in subjects within the highest quartiles of CD14+CD16+ monocytes (p=0.018). Our study showed that increased numbers of CD14+CD16+ monocytes are associated with coronary atherosclerosis and TNF-alpha. In accordance, recent animal studies suggest a possibly important role of these monocytes in the development of atherosclerosis.
Similar articles
-
Increased proatherogenic monocyte-platelet cross-talk in monocyte subpopulations of patients with stable coronary artery disease.J Intern Med. 2014 Feb;275(2):144-54. doi: 10.1111/joim.12145. Epub 2013 Oct 30. J Intern Med. 2014. PMID: 24118494
-
Xuemaitong granules attenuate carotid atherosclerosis by decreasing the expression of CD14+CD16+ monocytes, IL-6, TNF-α, and hsCRP.Genet Mol Res. 2014 Sep 12;13(3):7519-27. doi: 10.4238/2014.September.12.19. Genet Mol Res. 2014. PMID: 25222252
-
Senescent CD14+CD16+ monocytes exhibit proinflammatory and proatherosclerotic activity.J Immunol. 2011 Feb 1;186(3):1809-15. doi: 10.4049/jimmunol.1001866. Epub 2010 Dec 29. J Immunol. 2011. PMID: 21191073
-
The CD14+ CD16+ blood monocytes: their role in infection and inflammation.J Leukoc Biol. 2007 Mar;81(3):584-92. doi: 10.1189/jlb.0806510. Epub 2006 Nov 29. J Leukoc Biol. 2007. PMID: 17135573 Review.
-
CD14++ monocytes, CD14+/CD16+ subset and soluble CD14 as biological markers of inflammatory systemic diseases and monitoring immunosuppressive therapy.Clin Chem Lab Med. 1999 Mar;37(3):209-13. doi: 10.1515/CCLM.1999.039. Clin Chem Lab Med. 1999. PMID: 10353463 Review.
Cited by
-
Preclinical mouse models and methods for the discovery of the causes and treatments of atherosclerosis.Expert Opin Drug Discov. 2012 Mar;7(3):207-16. doi: 10.1517/17460441.2012.660143. Epub 2012 Feb 10. Expert Opin Drug Discov. 2012. PMID: 22468952 Free PMC article. Review.
-
Sex differences in monocyte activation in systemic lupus erythematosus (SLE).PLoS One. 2014 Dec 8;9(12):e114589. doi: 10.1371/journal.pone.0114589. eCollection 2014. PLoS One. 2014. PMID: 25485543 Free PMC article.
-
Correlation Between High-Density Lipoprotein and Monocyte Subsets in Patients with Stable Coronary Heart Disease.Med Sci Monit. 2015 Jun 2;21:3129-35. doi: 10.12659/msm.894485. Med Sci Monit. 2015. Retraction in: Med Sci Monit. 2016 Feb 08;22:415. doi: 10.12659/MSM.897961 PMID: 26474031 Free PMC article. Retracted.
-
Macrophage Phenotype and Function in Different Stages of Atherosclerosis.Circ Res. 2016 Feb 19;118(4):653-67. doi: 10.1161/CIRCRESAHA.115.306256. Circ Res. 2016. PMID: 26892964 Free PMC article. Review.
-
Heterozygous inactivation of the Nf1 gene in myeloid cells enhances neointima formation via a rosuvastatin-sensitive cellular pathway.Hum Mol Genet. 2013 Mar 1;22(5):977-88. doi: 10.1093/hmg/dds502. Epub 2012 Nov 29. Hum Mol Genet. 2013. PMID: 23197650 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous